ADDEX THERAPEUTICS LTD (ADXN) Stock Earnings & Estimates
USA - NASDAQ:ADXN - US00654J2069 - ADR
9.2 USD
-0.19 (-2.02%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.445M -54.17% | 1.617M 11.92% | 410K -74.65% | 765K 86.59% | 765K | -100.00% | |||||
| EBITDA YoY % growth | -20.197M -33.24% | -1.937M 90.41% | -2.495M -28.81% | -3.223M -29.18% | -3.284M -1.90% | -3.162M 3.73% | -2.546M 19.47% | -2.546M | -2.546M | -2.546M | |
| EBIT YoY % growth | -20.52M -32.34% | -2.243M 89.07% | -2.755M -22.84% | -3.305M -19.95% | -3.325M -0.62% | -3.162M 4.91% | -2.546M 19.47% | -2.546M | -2.546M | -2.546M | |
| Operating Margin | -1,420.08% | -138.70% | -672.00% | -432.00% | -434.67% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -9.54 76.96% | N/A -33.85% | N/A 103.68% | -6.57 -1,500.00% | -3.75 42.86% | 0.00 100.00% | -0.18 | -0.09 49.87% | 0.04 150.00% | N/A |
All data in CHF
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CHF
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -21.07 -576.64% | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 71.1K -70.60% | % | ||
| Q4 2024 Q2Q % growth | 398.2K 116.65% | % | ||
| Q3 2024 Q2Q % growth | 58.4K -82.26% | % | ||
| Q2 2024 Q2Q % growth | 115.3K -81.76% | % | ||
| Q1 2024 Q2Q % growth | 241.812K -51.84% | % | ||
| Q4 2023 Q2Q % growth | 183.8K -81.88% | % | ||
| Q3 2023 Q2Q % growth | 329.2K -20.81% | % | ||
| Q2 2023 Q2Q % growth | 632K 46.84% | % | ||
| Q1 2023 Q2Q % growth | 502.1K 105.78% | % | ||
| Q4 2022 Q2Q % growth | 1.015M -12.46% | % | ||
| Q3 2022 Q2Q % growth | 415.7K -45.14% | % | ||
| Q2 2022 Q2Q % growth | 430.4K -78.42% | % | ||
| Q1 2022 Q2Q % growth | 244K -73.55% | % | ||
| Q4 2021 Q2Q % growth | 1.159M -41.88% | % | ||
| Q3 2021 Q2Q % growth | 757.8K 637.88% | % | ||
| Q2 2021 Q2Q % growth | 1.994M 5.81% | % | ||
| Q1 2021 Q2Q % growth | 922.4K -3.16% | % | ||
| Q4 2020 Q2Q % growth | 1.994M 24.12% | % | ||
| Q2 2020 Q2Q % growth | 1.885M 53.62% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -16.67% |
| Revenue | N/A | N/A | 0% | 0% |